Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRI
Conditions: Pancreas Cancer; Adenocarcinoma Intervention: Sponsor: Groupe Hospitalier Paris Saint Joseph Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Borderline Tumor | Cancer | Cancer & Oncology | Neoadjuvant Therapy | Pancreas | Pancreatic Cancer | Research